Integrative Analysis of a Cancer Somatic Mutome

Overview

Journal Mol Cancer

Publisher Biomed Central

Specialties Molecular Biology
Oncology

Date 2007 Feb 7

PMID 17280605

Citations 17

Authors

Pilar Hernandez

Xavier Sole

Joan Valls

Victor Moreno

Gabriel Capella

Ander Urruticoechea

Miguel Angel Pujana

Affiliations

Soon will be listed here.

Abstract

Background: The consecutive acquisition of genetic alterations characterizes neoplastic processes. As a consequence of these alterations, molecular interactions are reprogrammed in the context of highly connected and regulated cellular networks. The recent identification of the collection of somatically mutated genes in breast tumors (breast cancer somatic "mutome") allows the comprehensive study of its function and organization in complex networks.

Results: We analyzed functional genomic data (loss of heterozygosity, copy number variation and gene expression in breast tumors) and protein binary interactions from public repositories to identify potential novel components of neoplastic processes, the functional relationships between them, and to examine their coordinated function in breast cancer pathogenesis. This analysis identified candidate tumor suppressors and oncogenes, and new genes whose expression level predicts survival rate in breast cancer patients. Mutome network modeling using different types of pathological and healthy functional relationships unveils functional modules significantly enriched in genes or proteins (genes/proteins) with related biological process Gene Ontology terms and containing known breast cancer-related genes/proteins.

Conclusion: This study presents a comprehensive analysis of the breast somatic mutome, highlighting those genes with a higher probability of playing a determinant role in tumorigenesis and better defining molecular interactions related to the neoplastic process.

Citing Articles

Suppression of OCT-1 in Metastatic Breast Cancer Cells Reduces Tumor Metastatic Potential, Hypoxia Resistance, and Drug Resistance.

Stepchenko A, Bulavkina E, Portseva T, Georgieva S, Pankratova E Life (Basel). 2022; 12(9).

PMID: 36143471 PMC: 9502003. DOI: 10.3390/life12091435.

Structure and Function of the Nuclear Pore Complex.

Petrovic S, Mobbs G, Bley C, Nie S, Patke A, Hoelz A Cold Spring Harb Perspect Biol. 2022; 14(12).

PMID: 36096637 PMC: 9732903. DOI: 10.1101/cshperspect.a041264.

Classification models for Invasive Ductal Carcinoma Progression, based on gene expression data-trained supervised machine learning.

Roy S, Kumar R, Mittal V, Gupta D Sci Rep. 2020; 10(1):4113.

PMID: 32139710 PMC: 7057992. DOI: 10.1038/s41598-020-60740-w.

Cell Line-, Protein-, and Sialoglycosite-Specific Control of Flux-Based Sialylation in Human Breast Cells: Implications for Cancer Progression.

Saeui C, Cho K, Dharmarha V, Nairn A, Galizzi M, Shah S Front Chem. 2020; 8:13.

PMID: 32117864 PMC: 7013041. DOI: 10.3389/fchem.2020.00013.

Ventricular Zone Expressed PH Domain Containing 1 (VEPH1): an adaptor protein capable of modulating multiple signaling transduction pathways during normal and pathological development.

Brown T, Kollara A, Shathasivam P, Ringuette M Cell Commun Signal. 2019; 17(1):116.

PMID: 31500637 PMC: 6734325. DOI: 10.1186/s12964-019-0433-4.

References

Fan W, Jin S, Tong T, Zhao H, Fan F, Antinore M . BRCA1 regulates GADD45 through its interactions with the OCT-1 and CAAT motifs. J Biol Chem. 2002; 277(10):8061-7. DOI: 10.1074/jbc.M110225200. View

Yasui K, Mihara S, Zhao C, Okamoto H, Saito-Ohara F, Tomida A . Alteration in copy numbers of genes as a mechanism for acquired drug resistance. Cancer Res. 2004; 64(4):1403-10. DOI: 10.1158/0008-5472.can-3263-2. View

Mootha V, Lepage P, Miller K, Bunkenborg J, Reich M, Hjerrild M . Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics. Proc Natl Acad Sci U S A. 2003; 100(2):605-10. PMC: 141043. DOI: 10.1073/pnas.242716699. View

Draghici S, Khatri P, Martins R, Ostermeier G, Krawetz S . Global functional profiling of gene expression. Genomics. 2003; 81(2):98-104. DOI: 10.1016/s0888-7543(02)00021-6. View

Zhong S, Li C, Wong W . ChipInfo: Software for extracting gene annotation and gene ontology information for microarray analysis. Nucleic Acids Res. 2003; 31(13):3483-6. PMC: 169004. DOI: 10.1093/nar/gkg598. View

Gupta S, Luong M, Bleuming S, Miele A, Luong M, Young D . Tumor suppressor pRB functions as a co-repressor of the CCAAT displacement protein (CDP/cut) to regulate cell cycle controlled histone H4 transcription. J Cell Physiol. 2003; 196(3):541-56. DOI: 10.1002/jcp.10335. View

Irizarry R, Hobbs B, Collin F, Beazer-Barclay Y, Antonellis K, Scherf U . Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003; 4(2):249-64. DOI: 10.1093/biostatistics/4.2.249. View

Ge H, Walhout A, Vidal M . Integrating 'omic' information: a bridge between genomics and systems biology. Trends Genet. 2003; 19(10):551-60. DOI: 10.1016/j.tig.2003.08.009. View

Bader G, Hogue C . An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics. 2003; 4:2. PMC: 149346. DOI: 10.1186/1471-2105-4-2. View

10.

Futreal P, Coin L, Marshall M, Down T, Hubbard T, Wooster R . A census of human cancer genes. Nat Rev Cancer. 2004; 4(3):177-83. PMC: 2665285. DOI: 10.1038/nrc1299. View

11.

Agudo D, Gomez-Esquer F, Martinez-Arribas F, Nunez-Villar M, Pollan M, Schneider J . Nup88 mRNA overexpression is associated with high aggressiveness of breast cancer. Int J Cancer. 2004; 109(5):717-20. DOI: 10.1002/ijc.20034. View

12.

Lin C, Strom A, Vega V, Kong S, Yeo A, Thomsen J . Discovery of estrogen receptor alpha target genes and response elements in breast tumor cells. Genome Biol. 2004; 5(9):R66. PMC: 522873. DOI: 10.1186/gb-2004-5-9-r66. View

13.

Arteaga C, Johnson M, Todderud G, Coffey R, Carpenter G, Page D . Elevated content of the tyrosine kinase substrate phospholipase C-gamma 1 in primary human breast carcinomas. Proc Natl Acad Sci U S A. 1991; 88(23):10435-9. PMC: 52943. DOI: 10.1073/pnas.88.23.10435. View

14.

Kim S, Wagner S, Liu F, OReilly M, Robbins P, Green M . Retinoblastoma gene product activates expression of the human TGF-beta 2 gene through transcription factor ATF-2. Nature. 1992; 358(6384):331-4. DOI: 10.1038/358331a0. View

15.

Emlet D, Moscatello D, Godwin A, Wong A . A Grb2-associated docking protein in EGF- and insulin-receptor signalling. Nature. 1996; 379(6565):560-4. DOI: 10.1038/379560a0. View

16.

Guan X, Xu J, Anzick S, Zhang H, Trent J, Meltzer P . Hybrid selection of transcribed sequences from microdissected DNA: isolation of genes within amplified region at 20q11-q13.2 in breast cancer. Cancer Res. 1996; 56(15):3446-50. View

17.

Nie J, Sakamoto S, Song D, Qu Z, Ota K, Taniguchi T . Interaction of Oct-1 and automodification domain of poly(ADP-ribose) synthetase. FEBS Lett. 1998; 424(1-2):27-32. DOI: 10.1016/s0014-5793(98)00131-8. View

18.

Kammerer S, Roth R, Reneland R, Marnellos G, Hoyal C, Markward N . Large-scale association study identifies ICAM gene region as breast and prostate cancer susceptibility locus. Cancer Res. 2004; 64(24):8906-10. DOI: 10.1158/0008-5472.CAN-04-1788. View

19.

Chang H, Nuyten D, Sneddon J, Hastie T, Tibshirani R, Sorlie T . Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci U S A. 2005; 102(10):3738-43. PMC: 548329. DOI: 10.1073/pnas.0409462102. View

20.

Vidal M . Interactome modeling. FEBS Lett. 2005; 579(8):1834-8. DOI: 10.1016/j.febslet.2005.02.030. View